Overview
Gonadorelin is a synthetic gonadotropin-releasing hormone (GnRH) that stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It’s designed to support gonadal function and has been studied as an alternative to hCG for maintaining testicular function in individuals on testosterone replacement therapy.
Key Quick-Start Information
– Reconstitution: Add 2.0 mL bacteriostatic water to create a 1.0 mg/mL concentration
– Standard dosing range: 100–250 mcg once daily
– Measurement convenience: At this concentration, 1 unit on a U-100 insulin syringe = 10 mcg
– Route: Subcutaneous injection
– Storage (lyophilized): Refrigerate at 2–8°C or freeze at −20°C long-term
– Storage (reconstituted): Refrigerate at 2–8°C; do not freeze
– Reconstituted shelf life: Use within 30 days
Dosing Protocol — Gradual Titration Approach
| Week(s) | Daily Dose | Insulin Syringe Units |
|---|---|---|
| 1–2 | 100 mcg (0.1 mg) | 10 units (0.10 mL) |
| 3–4 | 150 mcg (0.15 mg) | 15 units (0.15 mL) |
| 5–8 | 200 mcg (0.2 mg) | 20 units (0.20 mL) |
| 9–12 | 250 mcg (0.25 mg) | 25 units (0.25 mL) |
Frequency: Once daily subcutaneous injection maintains optimal pulsatile-like LH/FSH release patterns.
Cycle length: 8–12 weeks standard; optional extension to 16 weeks with medical guidance.
Reconstitution Steps
1. Draw 2.0 mL bacteriostatic water with a sterile syringe
2. Inject slowly down the vial wall; avoid foaming
3. Gently swirl or roll until dissolved (do not shake)
4. Label with reconstitution date and store refrigerated at 2–8°C, protected from light
Supplies Needed (Example for 12-Week Protocol)
– Peptide vials: 9 vials (2 mg each)
– Insulin syringes (U-100): 84 syringes (7 per week)
– Bacteriostatic water: 18 mL (approximately 2 x 10 mL bottles)
– Alcohol swabs: 168 swabs (2 per day; recommend 2 x 100-count boxes)
Mechanism of Action
“Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH) that stimulates the anterior pituitary to release” LH and FSH. In individuals suppressed by testosterone therapy, it helps restore the GnRH/LH signaling pathway. Research indicates pulsatile GnRH therapy shows superior results compared to hCG for promoting testicular growth in hypogonadal patients.
Potential Benefits
– Supports natural LH and FSH production to maintain gonadal function during testosterone therapy
– May help preserve testicular size and function
– Evidence suggests superior efficacy compared to hCG in adolescent hypogonadism
– Generally well tolerated
Side Effects & Considerations
– Occasional mild injection-site reactions (redness, itching) may occur
– Excessively high or frequent dosing can lead to pituitary receptor downregulation, reducing effectiveness
– Adherence to recommended dosing ranges is important
Injection Technique
– Clean vial stopper and injection site with alcohol; allow ~30 seconds air-dry time
– Choose appropriate site: lower abdomen (at least 2 inches from navel), outer thigh, or outer upper arm
– Pinch skinfold; insert needle at 45–90° depending on subcutaneous fat
– Do not aspirate for subcutaneous injections
– Inject slowly and steadily
– Apply gentle pressure with gauze; do not rub or massage the site
– Rotate injection sites systematically to avoid lipohypertrophy and tissue irritation
– Dispose of syringes immediately in a sharps container
Storage Instructions
Lyophilized vials:
– Refrigerate at 2–8°C (36–46°F) or −20°C (−4°F) for long-term storage
– Protect from light and moisture
Reconstituted solution:
– Refrigerate at 2–8°C; do not freeze
– Use within 30 days when refrigerated
– Allow vials to reach room temperature before opening to reduce condensation
Lifestyle Support Factors
– Maintain balanced diet with adequate protein, healthy fats, and micronutrients
– Engage in regular resistance training and cardiovascular exercise
– Prioritize 7–9 hours of quality sleep per night
– Manage stress through mindfulness and recovery practices
– Avoid excessive alcohol and endocrine disruptors
Important Notes
– Use new sterile insulin syringes for each injection
– Mark reconstitution date on each vial
– Document daily dose and site rotation for consistency
– This content is for research and educational purposes only
– Not for human consumption
– Consult qualified healthcare provider before beginning any protocol
– Individual responses may vary; medical supervision is essential
Disclaimer
This information is educational only and does not constitute medical advice, diagnosis, or treatment. Gonadorelin is for research use only and is not approved for human consumption.